217 related articles for article (PubMed ID: 12176625)
1. Tacrolimus versus cyclosporine in primary simultaneous pancreas-kidney transplantation: preliminary results at 1 year of a large multicenter trial.
Land W; Malaise J; Sandberg J; Langrehr J;
Transplant Proc; 2002 Aug; 34(5):1911-2. PubMed ID: 12176625
[No Abstract] [Full Text] [Related]
2. Efficacy and safety of tacrolimus versus cyclosporine in kidney and pancreas transplant recipients.
el-Ghoroury M; Hariharan S; Peddi VR; Munda R; Schroeder TJ; Demmy AM; Alexander JW; First MR
Transplant Proc; 1997; 29(1-2):649-51. PubMed ID: 9123461
[No Abstract] [Full Text] [Related]
3. Antilymphocyte induction is no longer necessary in simultaneous pancreas and kidney transplantation.
Rigotti P; Baldan N; Cadrobbi R; Furian L; Sarzo G; Dall'Olmo L; Ancona E
Transplant Proc; 2002 Aug; 34(5):1906-8. PubMed ID: 12176623
[No Abstract] [Full Text] [Related]
4. Cyclosporine therapy in pancreas transplantation.
Davidson I; Lu C; Melone D; Risser R
Transplant Proc; 1996 Aug; 28(4):2134-5. PubMed ID: 8769179
[No Abstract] [Full Text] [Related]
5. Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation.
Bruce DS; Woodle ES; Newell KA; Millis JM; Cronin DC; Loss GE; Grewal HP; Siegel CT; Pellar S; Josephson MA; Thistlethwaite JR
Transplant Proc; 1998 Jun; 30(4):1538-40. PubMed ID: 9636625
[No Abstract] [Full Text] [Related]
6. FK 506 induction and rescue therapy in pancreas transplant recipients.
Stratta RJ; Taylor RJ; Castaldo P; Sindhi R; Sudan D; Weide LG; Frisbie K; Cushing KA; Jerius J; Radio SJ
Transplant Proc; 1996 Apr; 28(2):991-2. PubMed ID: 8623492
[No Abstract] [Full Text] [Related]
7. Tacrolimus (FK 506) in kidney transplantation: three-year survival results of the US multicenter, randomized, comparative trial. FK 506 Kidney Transplant Study Group.
Jensik SC
Transplant Proc; 1998 Jun; 30(4):1216-8. PubMed ID: 9636494
[No Abstract] [Full Text] [Related]
8. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience.
Alloway RR; Russell WC; Gaber LW; Amiri MH; Vera SR; Gaber AO
Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494
[No Abstract] [Full Text] [Related]
9. Single-center experience of 60 consecutive simultaneous pancreas-kidney transplants using mycophenolate mofetil and tacrolimus as primary maintenance immunotherapy.
Kaufman DB; Leventhal JR; Stuart J; Parker M; Abecassis M; Fryer JP; Stuart FP
Transplant Proc; 1999; 31(1-2):615-6. PubMed ID: 10083261
[No Abstract] [Full Text] [Related]
10. Mycophenolate mofetil/prednisolone/single-shot ATG with tacrolimus or cyclosporine in pancreas/kidney transplantation: first results of an ongoing prospective randomized trial.
Schulz T; Konzack J; Büsing M
Transplant Proc; 1999; 31(1-2):591-2. PubMed ID: 10083251
[No Abstract] [Full Text] [Related]
11. Tacrolimus/mycophenolate mofetil vs cyclosporine A/Azathioprine after simultaneous pancreas and kidney transplantation: five-year results of a randomized study.
Woeste G; Wullstein C; Dette K; Pridöhl O; Lübke P; Bechstein WO
Transplant Proc; 2002 Aug; 34(5):1920-1. PubMed ID: 12176629
[No Abstract] [Full Text] [Related]
12. Tacrolimus-based vs cyclosporine-based immunotherapy in combined kidney-pancreas transplantation.
Ketel BL; Turton-Weeks S; Reed K; Barone GW
Transplant Proc; 1996 Apr; 28(2):899. PubMed ID: 8623453
[No Abstract] [Full Text] [Related]
13. Low incidence of rejection after synchronous pancreas-kidney transplantation with Neoral.
Cattral MS; Hemming AW; Greig PD; Rowsell C; Chari R; Wright E; Donat D; Cole E; Levy GA
Transplant Proc; 1998 Aug; 30(5):1946. PubMed ID: 9723346
[No Abstract] [Full Text] [Related]
14. Immunosuppressive drugs after simultaneous pancreas-kidney transplantation.
Malaise J; Kuypers DR; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y; Van Ophem D; Squifflet JP;
Transplant Proc; 2005; 37(6):2840-2. PubMed ID: 16182827
[TBL] [Abstract][Full Text] [Related]
15. Long-term results of pancreas transplantation under tacrolius immunosuppression.
Jordan ML; Shapiro R; Gritsch HA; Egidi F; Khanna A; Vivas CA; Scantlebury VP; Fung JJ; Starzl TE; Corry RJ
Transplantation; 1999 Jan; 67(2):266-72. PubMed ID: 10075592
[TBL] [Abstract][Full Text] [Related]
16. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
[TBL] [Abstract][Full Text] [Related]
17. Tacrolimus (FK 506) therapy in simultaneous pancreas kidney transplantation.
Becker G; Witzke O; Friedrich J; Wagner K; Heemann U; Philipp T
Transplant Proc; 1996 Dec; 28(6):3169-70. PubMed ID: 8962228
[No Abstract] [Full Text] [Related]
18. Tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: the EURO-SPK 3-year results.
Malaise J; Saudek F; Boucek P; Adamec M; Van Ophem D; Squifflet JP;
Transplant Proc; 2005; 37(6):2843-5. PubMed ID: 16182828
[TBL] [Abstract][Full Text] [Related]
19. Tacrolimus versus cyclosporine as primary prophylactic therapy after cadaveric renal transplant: two-year survival study.
Wong KM; Cheung CY; Chan YH; Chak WL; Choi KS; Chau KF; Li CS
Transplant Proc; 2000 Nov; 32(7):1721-2. PubMed ID: 11119907
[No Abstract] [Full Text] [Related]
20. Comparison of MPA trough levels in patients with severe diabetes mellitus and from non-diabetics after transplantation.
Zanker B; Sohr B; Eder M; Frohmann E; Land W
Transplant Proc; 1999; 31(1-2):1167. PubMed ID: 10083521
[No Abstract] [Full Text] [Related]
[Next] [New Search]
